To investigate the effects of ACLY inhibitor BMS‐303141 on ESCC proliferation, a CCK‐8 kit was used to detect the effect of BMS‐303141 on the survival rate of ESCC cells. Here, ACLY is linked to esophageal squamous cell carcinoma.